"Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease." by Katherine R. Tuttle

Selected Works of Katherine R. Tuttle, MD, FASN, FACP, FNKF

Follow Contact

Article

Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease.

Clinical Journal of The American Society of Nephrology (2019)

Katherine R. Tuttle, University of Washington
Katherine R. Tuttle, Providence Health Care
David Z. Cherney, Toronto General Hospital

Link

Disciplines

Endocrinology, Diabetes, and Metabolism,
Critical Care,
Internal Medicine and
Medicine and Health Sciences

Publication Date

November 18, 2019

DOI

10.2215/CJN.07730719

Citation Information

Katherine R. Tuttle, Katherine R. Tuttle and David Z. Cherney. "Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease." Clinical Journal of The American Society of Nephrology (2019)
Available at: http://works.bepress.com/katherine-tuttle/220/